Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ekaterina Urch

Sports Medicine Bend, OR Medical Doctor

NPI 1548550890 CMS profile 2784111

2200 Ne Neff Rd Ste 200, Bend, OR 97701

Open in the dashboard

General payments

$41,183

172 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ekaterina Urch of Bend, OR is reported in the CMS Open Payments database as having received $41,183 across 172 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,269 44
2024 General $5,795 37
2023 General $5,114 21
2022 General $4,333 25
2021 General $10,317 29
2020 General $2,196 9
2019 General $159 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ekaterina Urch
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Ekaterina Urch were reported at $13,269. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Ekaterina Urch Sports Medicine median Middle half National median
2019 $159 $1,176 $199–$4,249 $163
2020 $2,196 $708 $96–$2,890 $114
2021 $10,317 $1,213 $152–$3,994 $132
2022 $4,333 $1,230 $159–$3,998 $149
2023 $5,114 $584 $146–$2,836 $160
2024 $5,795 $628 $163–$3,168 $164
2025 $13,269 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $15,499 69 payments
  2. Steelhead Surgical Inc $15,083 42 payments
  3. Shoulder Innovations, Inc. $3,949 13 payments
  4. Stryker Corporation $3,592 22 payments
  5. Vericel Corporation $2,019 2 payments
  6. DePuy Synthes Sales Inc. $344 6 payments
  7. Left Coast Surgical Inc $173 1 payment
  8. Wildwood Medical LLC $140 3 payments
  9. Miach Orthopaedics, Inc. $119 1 payment
  10. Ferring Pharmaceuticals Inc. $87 6 payments
  11. Other $176 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $12,963 37 payments
  2. Education $10,342 10 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,250 5 payments
  4. Food and Beverage $6,565 117 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $2,000 1 payment
  6. Gift $63 2 payments
Products named General payments · program years 2019–2025
  1. InSet System $3,949 13 payments
  2. MACI $2,000 1 payment
  3. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $1,283 11 payments
  4. AEQUALIS PERFORM $1,195 2 payments
  5. MAKO $636 1 payment
  6. KNEE & HIP IMPLANTS SUSPENSORY FIXATION ACL TIGHTROPE $187 2 payments
  7. FIBERGRAFT Aeridyan Matrix $148 1 payment
  8. HEADLESS COMPRESSION SCREWS $99 1 payment
  9. TORNIER PERFORM REVERSED AUGMENTED GLENOID $92 1 payment
  10. EUFLEXXA $87 6 payments
  11. Other $568 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

233

Median for Orthopedic Surgery: 203

Drug cost

$2,300

Median for Orthopedic Surgery: $1,433

Branded share of claims

27.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Er Diclofenac Sodium Brand 64 $1,247
Diclofenac Sodium Generic 91 $446
Celecoxib Generic 11 $443
Tramadol Hcl Generic 16 $53
Meloxicam Generic 13 $49
Amoxicillin Generic 26 $32
Oxycodone Hcl Generic 12 $29

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$115,593

Of which drugs: $6,212

Medicare patients

470

Average age 72

Services billed

2,208

275 women, 195 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 70%
High blood pressure 57%
Ischemic heart disease 23%
Depression 22%
Osteoporosis 17%
Cancer 15%
Diabetes 14%
COPD 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 130 632 $460

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

172 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record